{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:02:14Z","timestamp":1786737734281,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1319-2442.308335","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T08:25:37Z","timestamp":1611908737000},"page":"1263","source":"Crossref","is-referenced-by-count":9,"title":["Diagnosis of iron deficiency in hemodialysis patients: Usefulness of measuring reticulocyte hemoglobin equivalent"],"prefix":"10.4103","volume":"31","author":[{"given":"Dawlat","family":"Sany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"El Shahawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenan","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-2442.308335-1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000186401","article-title":"Improved physical performance after treatment of renal anemia with recombinant human erythropoietin","author":"Braumann","year":"1991","journal-title":"Nephron"},{"key":"key-10.4103\/1319-2442.308335-2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0272-6386(12)80079-5","article-title":"Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients","author":"Robertson","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.308335-3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0272-6386(89)80148-9","article-title":"Recombinant human erythro-poietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients","author":"Wolcott","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.308335-4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease","author":"Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.308335-5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.1990.03440060071035","article-title":"The quality of life of hemodialysis recipients treated with recombinant human erythro-poietin.Cooperative Multicenter EPO Clinical Trial Group","author":"Evans","year":"1990","journal-title":"JAMA"},{"key":"key-10.4103\/1319-2442.308335-6","first-page":"14","article-title":"Improvement in quality of life following treatment with r-HuEPO in anemic hemodialysis patients","author":"Delano","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.308335-7","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/ndt\/13.7.1642","article-title":"The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity \u2013 The experience of the Lombardy Dialysis Registry","author":"Locatelli","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.308335-8","first-page":"ii1","article-title":"Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.308335-9","first-page":"S11","article-title":"National Kidney Foundation.KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease","author":"KDOQI","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.308335-10","first-page":"471","article-title":"KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target","author":"KDOQI","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.308335-11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0272-6386(97)90192-X","article-title":"Iron management in end-stage renal disease","author":"Fishbane","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.308335-12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/oxfordjournals.ndt.a027459","article-title":"Regular low-dose intravenous iron therapy improves response to erythropoietin in haemo-dialysis patients","author":"Taylor","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.308335-13","doi-asserted-by":"crossref","unstructured":"Coyne D. Challenging the boundaries of anemia management: A balanced approach to i.v. iron and EPO therapy. Kidney Int Suppl 2006;101:S1-3.","DOI":"10.1038\/sj.ki.5000402"},{"key":"key-10.4103\/1319-2442.308335-14","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/16.7.1416","article-title":"The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin","author":"Tessitore","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.308335-15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1309\/W65295DTUWK7U1HH","article-title":"The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100: Its use in the diagnosis and monitoring of posttreatment sideropenic anemia","author":"Buttarello","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/1319-2442.308335-16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1373\/clinchem.2004.030254","article-title":"Potential utility of Ret-Y in the diagnosis of iron-restricted erythropoiesis","author":"Franck","year":"2004","journal-title":"Clin Chem"},{"key":"key-10.4103\/1319-2442.308335-17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2014.275","article-title":"Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality","author":"Bailie","year":"2015","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.308335-18","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1046\/j.1523-1755.2001.00077.x","article-title":"A randomized trial of iron deficiency testing strategies in hemodialysis patients","author":"Fishbane","year":"2001","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.308335-19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5414\/CNP57136","article-title":"Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients","author":"Chang","year":"2002","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/1319-2442.308335-20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/sj.ki.5002223","article-title":"Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation","author":"Singh","year":"2007","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.308335-21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.299.6692.157","article-title":"Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously","author":"Macdougall","year":"1989","journal-title":"BMJ"},{"key":"key-10.4103\/1319-2442.308335-22","first-page":"712","article-title":"Iron status in patients receiving erythropoietin for dialysis-associated anemia","author":"Van","year":"1989","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.308335-23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/jpme.1995.23.1-2.83","article-title":"The hypochromic red cell: A new parameter for monitoring of iron supplementation during rHuEPO therapy","author":"Schaefer","year":"1995","journal-title":"J Perinat Med"},{"key":"key-10.4103\/1319-2442.308335-24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ndt\/14.3.659","article-title":"Hypochromic red cells and reticulocyte haemglobin content as markers of iron-deficient erythro-poiesis in patients undergoing chronic haemodialysis","author":"Cullen","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.308335-25","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood.V75.9.1870.1870","article-title":"Serum transferrin receptor: A quantitative measure of tissue iron deficiency","author":"Skikne","year":"1990","journal-title":"Blood"},{"key":"key-10.4103\/1319-2442.308335-26","first-page":"246","article-title":"Soluble transferrin receptor is correlated with erythro-poietin sensitivity in dialysis patients","author":"Daschner","year":"1999","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/1319-2442.308335-27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ajcp\/102.5.623","article-title":"Automated reticulocyte counting and measurement of reticulocyte cellular indices.Evaluation of the Miles HFNx013 blood analyzer","author":"Brugnara","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/1319-2442.308335-28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2257.2006.00812.x","article-title":"Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states","author":"Brugnara","year":"2006","journal-title":"Clin Lab Haematol"},{"key":"key-10.4103\/1319-2442.308335-29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1309\/AJCPQAX0JFHFS0OA","article-title":"Diagnosis of iron deficiency in patients undergoing hemodialysis","author":"Buttarello","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/1319-2442.308335-30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1532\/LH96.06037","article-title":"Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy","author":"Garzia","year":"2007","journal-title":"Lab Hematol"},{"key":"key-10.4103\/1319-2442.308335-31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/pr.2012.162","article-title":"Evaluating iron status and the risk of anemia in young infants using erythrocyte parameters","author":"Torsvik","year":"2013","journal-title":"Pediatr Res"},{"key":"key-10.4103\/1319-2442.308335-32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cca.2011.12.006","article-title":"Reticulocyte hemoglobin content allows early and reliable detection of functional iron deficiency in blood donors","author":"Semmelrock","year":"2012","journal-title":"Clin Chim Acta"},{"key":"key-10.4103\/1319-2442.308335-33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2012.09.001","article-title":"Is analysis of the reticulocyte haemoglobin equivalent a useful test for the diagnosis of iron deficiency anaemia in geriatric patients?","author":"Joosten","year":"2013","journal-title":"Eur J Int Med"},{"key":"key-10.4103\/1319-2442.308335-34","first-page":"925907","article-title":"Comparative evaluation of the reticulocyte hemoglobin content assay when screening for iron deficiency in elderly anemic patients","author":"Karlsson","year":"2011","journal-title":"Anemia"},{"key":"key-10.4103\/1319-2442.308335-35","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.4081\/hr.2012.e24","article-title":"Effects of iron supplementation on red blood cell hemoglobin content in pregnancy","author":"Schoorl","year":"2012","journal-title":"Hematol Rep"},{"key":"key-10.4103\/1319-2442.308335-36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1751-553X.2009.01179.x","article-title":"Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency","author":"Miwa","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"key-10.4103\/1319-2442.308335-37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/ijlh.12013","article-title":"Erythrocyte and reticulocyte indices in the assessment of erythropoiesis activity and iron availability","author":"Urrechaga","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"key-10.4103\/1319-2442.308335-38","first-page":"1411","article-title":"Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism","author":"Urrechaga","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"key-10.4103\/1319-2442.308335-39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/ijlh.12496","article-title":"Percentage of hypochromic erythrocytes and reticulocyte hemoglobin equivalent predictors of response to intravenous iron in hemodialysis patients","author":"Urrechaga","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"key-10.4103\/1319-2442.308335-40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5935\/1676-2444.20150014","article-title":"New red blood cell and reticulocyte parameters and reference values for healthy individuals and in chronic kidney disease","author":"Scherer","year":"2015","journal-title":"J Bras Patol Med Lab"},{"key":"key-10.4103\/1319-2442.308335-41","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.ajkd.2008.12.040","article-title":"Predictors of hyporesponsiveness to erythro-poiesis-stimulating agents in hemodialysis patients","author":"Kalantar-Zadeh","year":"2009","journal-title":"Am J Kidney Dis"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:58:41Z","timestamp":1786733921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.308335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"alternative-id":["308335"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.308335","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}